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Studies analyzing the specificity of receptors on thymus-derived (T)  cells and their 
ability to distinguish  between  structurally related  antigens  in  comparison to that of 
humoral antibody has provided insight into the nature of the T-cell receptor (1, 2). One 
approach to directly evaluate the specificity of a particular subpopulation of T cells is to 
assay for cytotoxicity in the cell-mediated lympholysis (CML) assay. Evidence that the 
cytotoxic T cell recognizes specific  antigen includes the findings that such cells  can be 
absorbed on antigen-specific monolayers, T-cell-mediated cytotoxicity can be blocked by 
adding an excess of unlabeled antigen-bearing target cells,  and antisera against struc- 
tures recognized by these T cells blocks killing (reviewed in 3). 
Cytotoxic T-cell activity has  been  examined in  detail  against trinitrophenyl(TNP)- 
modified syngeneic cells  (3,  4).  The specificity of this  response has  been  shown to be 
controlled by the H-2  gene  complex in that cytotoxic effector cells generated  against 
syngeneic TNP-modified stimulator cells express cytotoxicity against only H-2-related 
TNP-modified target  cells  (4,  5).  In  addition,  cross-reactivity of the  cytotoxic T-cell 
response towards cells derivatized with different haptens does not occur to a significant 
extent (6). 
In the present experiments I have tested the specificity of the cytotoxic effect 
of splenic T  cells sensitized against either TNP- or dinitrophenyl  (DNP)-modi- 
fled spleen cells  in the  CML assay.  Since these haptens  are  structurally very 
similar  and couple to proteins by attaching primarily to the same amino acid 
residues  (7),  the fine specificity of the receptor on the cytotoxic T  cell  and its 
ability  to  discriminate  between  closely  related  antigenic  molecules  can  be 
analyzed. 
Materials and Methods 
Generation of Cytotoxic Effector Cells, Preparation of Target Cells,  and Assay for CML Activ- 
ity.  The method used for generating and assaying cytotoxic T-cell activity against TNP-modified 
spleen cells has been described in detail in previous communications (5, 8). The method used to 
generate  anti-DNP-cytotoxic cells was identical to that used to generate  anti-TNP  effector cells 
with the following exceptions: stimulator  or target cells were suspended at a concentration of 3 × 
107 celts/ml in a 10-mM solution of dinitrobenzenesulfonic acid (DNBS) (Eastman Organic Chemi- 
cals Div., Eastman Kodak Co., Rochester, N. Y.) in phosphate-buffered saline at pH 8.5 for 30 min 
at 37  ° C.  After this  treatment,  the  cells were  washed two times  in  a balanced  salt  solution 
containing 5% fetal calf serum before use. 
* Supported by National  Institutes of Health grant AI-13111. 
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TABLE  I 
Specificity of Splenic Effector  Cells Sensitized to TNP- or DNP-Modified Stimulator 
Cells* 
Responder  Stimulator  Target  Inhibitor 
Net release* 
Experiment number 
1  2  3§  4 
BALB/c  BALB/c-TNP  BALB/c-TNP  16.3  49.3  31.4 
BALB/c-DNP  BALB/c-TNP  0.1  5.7  13.3 II 
BALB/c-DNP  BALB/c-DNP  8.5  14.6  10.4 
BALB/c-TNP  BALBIc-DNP  -0.6  6.6  -6.1 
BALB rc-TNP  BALE/c-TNP 
BALB/c¶ 
(0.5 × 10  ~) 
(1 × 10  e) 
BALB/c-TNP 
(0.5 × 10  ~) 
(1 x 10  6) 
BALB/c-DNP 
(0.5  ×  10  6) 
(i x 10  ~) 
22.2 
17.1 (23)** 
18.6 (16) 
9.3 (58) 
8.4 (62) 
27.9 (-26) 
20.1 (9) 
* Effector to target cell  ratio,  100:1,  target cells  are 104 ~Cr-labeled  Con A lymphoblasts. 
$ Net release ffi  isotope  release in the presence of  immune cells  - nonimmune  cells. 
§ A/J rather than BALB/c cells  were used. 
]]  The croes-reactivity  observed in experiment 3 was not noted in three additional experiments (date not shown). 
¶ Unlabeled Con A lymphoblasts;  numbers in parentheses  indicate number of inhibitor  cells  added. 
** Number in parentheses  indicates percent inhibition of  net release (See reference 8). 
The  spontaneous isotope  release  from target  cells  ranged from 25  to  35%  for TNP-modified 
targets and from 25 to 48% for DNP-modified targets. 
Cold Target Competition Assay.  The method used is identical to that described in a  previous 
communication (5).  In Vivo Immunization of  Animals with Haptenated  Cells.  Spleen cells were 
modified with trinitrobenzenesulfonic acid (TNBS) or DNBS, adjusted to a  concentration of 40  x 
10  s cells/ml, and each mouse received 0.25 ml of the suspension intraperitoneally. The concentra- 
tion of TNBS and DNBS used for derivatization of the spleen cells was 10 raM.  7-10  days a~er 
priming,  the  animals  were  sacrificed,  their  spleens removed,  and  the  cells  used  for  in  vitro 
culturing in the CML assay. 
Results 
Specificity of the Primary CML Response against TNP- and DNP-Modified 
Syngeneic Cells.  BALB/c or A/J spleen cells sensitized against TNP-modified 
stimulator cells displayed a cytotoxic effect against TNP-modified concanavalin 
A  (Con A) lymphoblast targets  (Table I). If the spleen cells were sensitized to 
DNP-modified stimulators,  however, little or no cytotoxicity was seen against 
TNP-modified target cells. The same result occurred in the reciprocal direction; 
that  is,  spleen  cells  sensitized  against  DNP-medified  stimulators  exerted  a 
cytotoxic effect against  DNP-modified targets,  but not when they were sensi- 
tized with TNP-modified stimulators.  In  all  experiments,  a  lower net isotope 
release was observed with anti-DNP effector cells compared to anti-TNP effec- 
tors. In addition, the spontaneous release from target cells modified with DNBS 
was generally higher due to the conditions used for modification (see Materials 
and Methods). 
Specificity of the Secondary CML Response against TNP- and DNP-Modified 
Target  Cells.  While  the  specificity of the  primary  immune  response  in  the 
CML test was specific for either TNP- or DNP-modified target cells, it is possible 
that during in vivo priming,  cross-reactive anti-hapten  T-cell clones are sensi- 602  JAMES  FORMAN  BRIEF  DEFINITIVE  REPORT 
TABLE  II 
Specificity  of the Cytotoxic Effect of Spleen Cells from Primed Mice RechaUenged  In 
Vitro and Tested against TNP- or DNP-Modified Targets* 
Line  Responders  Stimulators  Targets  Net isotope  release 
i  BALB/c 
Imm-TNP$  BALB/c-TNP  BALB/e-TNP  37.6 
BALB/c 
Imm-TNP  BALB/c-DNP  BALB/c-TNP  6.1 
2  BALB/c 
Imm-DNP~  BALB/c-DNP  BALB/coDNP  33.4 
BALB/c 
Imm-DNP  BALB/c-TNP  BALB/c-DNP  8.2 
3  BALB/c 
Imm-TNP  BALB/c-TNP  BALB/c  -  3,4 
BALB/c 
Imm-DNP  BALB/c-DNP  BALB/c  -  2.1 
4  BALB/c 
Imm-TNP  BALB/c-TNP  BALB/c-DNP  2.1 
BALB/c 
Imm-TNP  BALB/c-DNP  BALB/c-DNP  15.5 
5  BALB/c 
Imm-DNP  BALB/c-DNP  BALB/c-TNP  12.0 
BALB/c 
Imm-DNP  BALB/coTNP  BALB/c-TNP  38.0 
* See footnote  * in Table I. 
Spleen cells  from mice primed with TNP- or DNP-modified spleen cells  7-10 days previously were rechallenged in vitro  with 
hapten-modified cells. 
tized,  or that cells with receptors of higher  avidities are activated which may 
give rise to cross-reactivity in a secondary cytotoxic response. Therefore, spleen 
cells from animals primed with TNP-modified spleen cells were cultured in vitro 
with TNP- or DNP-modified stimulator cells and then tested for their cytotoxic 
potential against TNP-modified target cells. The results indicate (Table II, line 
1) that strong cytotoxicity was observed only when the in vitro stimulator and 
target  cells were derivatized  with  the  same hapten.  Thus,  mice primed  with 
TNP-modified cells in vivo and rechallenged in vitro with DNP-modified stimu- 
lator cells did not cross kill TNP-modified targets to a  significant  extent.  The 
same negative result was seen with spleen cells from animals primed to DNP- 
modified cells, rechallenged with TNP-modified stimulators,  and tested against 
DNP-modified targets (Table II, line 2). Evidence that the cytotoxic response is 
specific is shown by the finding that the in vivo-primed and in vitro challenged 
effector cells show no cytotoxic activity against target cells that are not hapten- 
ated (Table II, line 3). 
To further assess the specificity of cells from mice primed in vitro with hapten- 
modified  cells,  I  rechallenged  splenocytes  from  animals  primed  with  TNP- 
modified cells in vivo with TNP-modified stimulators  and tested for cytotoxic 
activity against DNP-modified targets.  The results  (Table II, line 4) show that 
no cytotoxic activity resulted.  However, if the TNP immune spleen cells were 
cultured in vitro with  DNP-modified stimulators  cells,  cytotoxicity was noted 
against DNP-modified target cells as expected, reflecting a primary anti-DNP- 
CML  response.  When  animals  were  immunized  in  vivo  with  DNP-modified 
cells, rechallenged in vitro with DNP-modified stimulators,  and tested against 
TNPomodified targets,  some cytotoxic activity resulted (Table II, line 5). How- 
ever,  it was considerably less than  seen against the specific targets  (compare 
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cells were rechallenged with TNP-modified stimulators and tested against TNP- 
modified targets  (again reflecting a  primary in vitro CML response). 
Additional data indicates that the cytotoxicity can be completely abrogated by 
treating the effector cells with an anti-T-cell serum and complement, and serum 
from primed mice has no effect on inducing  antibody-dependent cell-mediated 
cytotoxicity in vitro (data not shown). 
Specificity of TNP Sensitized Effector Cells as  Assessed  by  a  Cold  Target 
Competition  Assay.  To  more  directly  assess  the  specificity of the  cytotoxic 
effector cells for these two haptens, I sensitized BALB/c spleen cells in vitro with 
TNP-modifled  stimulators  and  determined  the  ability  of unlabeled  hapten- 
modified Con A lymphoblasts to block the specific cytotoxic effect of the effector 
cells generated. The results (Table I) show that spleen cells sensitized with TNP- 
modified stimulator cells are cytotoxic for TNP-modified target cells. The addi- 
tion  of a  50-  to  100-fold excess of unlabeled  TNP-modified  inhibitor  cells  in 
relation  to  labeled targets  blocked a  large  proportion  of the  cytotoxic effect. 
However, target cells unmodified or modified with DNBS show little blocking 
and in some cases enhancement of activity in the CML assay. 
Discussion 
The fact that  antigen-specific receptors on cytotoxic T  cells can distinguish 
between DNP-  and  TNP-modifled  cells indicates  that  the  T-cell  receptor can 
discriminate  between  two  closely  related  haptenic  molecules.  Although  the 
hapten plays an important role in antigen recognition by T cells, the neighbor- 
ing amino acids to which small haptenic molecules are attached play a critical 
role in determining T-cell specificity (9). Thus, it is possible that T cells may be 
able to discriminate between DNP- and TNP-modified cells not on the basis of 
the  meta  nitro  group,  but  rather  by the  fact  that  the  nitrophenyl  haptens 
coupled to different amino acid residues. However, under the conditions used for 
modification in this study, the predominant residue derivatized by both of these 
haptens  is the E-amino  group of lysine  (7).  Although these haptens  may also 
couple to nonprotein  cell membrane  components,  we have found that  greater 
than 70% of labeled (3H) TNBS attaches to plasma membrane proteins. 1 There- 
fore, the  ability of the T  cell to distinguish  between TNP- and  DNP-modified 
cells is most likely the result of the receptor discriminating between differences 
in the two haptens themselves, rather than adjacent amino acids. 
The specificity of T  cells for these two haptens  has been examined in other 
assays including delayed type hypersensitivity responses (10), and T-cell prolif- 
eration assays in vitro  (2).  While  such responses are characterized  by hapten 
specificity, some cross-reactivity is observed between DNP and TNP derivatized 
proteins (2, 10). Since none of these assays measure T-cell binding, but rather an 
activity that follows as a consequence of antigen recognition, this cross-reactiv- 
ity may in part be due to biological amplification and recruitment  (11). 
The specificity of cytotoxic T cells sensitized to hapten-modifled cells and the 
H-2  genetic  restriction  can  be explained  by two different hypotheses  (3,  12). 
Forman,  J.,  E.  S.  Vitetta,  and  D.  A.  Hart.  Relationship between trinitrophenyl  and  H-2 
antigens on trinitrophenyl-modified spleen cells. III. Quantitation of trinitrophenol molecules and 
trinitrophenyl-derivatized  H-2 antigens  on cells that  specifically block cytotoxic effeetor cells. 
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According to the  altered  self interpretation  of T-cell-mediated cytotoxicity, T 
cells bear one clonally distributed  receptor that  recognizes  H-2 controlled cell 
surface antigens  which have been altered by extrinsic  antigens  (haptens  and 
viruses),  extrinsic  antigens  that  have  been  altered  by H-2 gene  products,  or 
some type of interaction antigen. In contrast, the dual receptor hypothesis states 
that T cells have two receptors, one clonally distributed and specific for antigen, 
the second receptor directed towards a self H-2 gene product. In this case, T-cell 
recognition  would  occur  as  a  result  of these  two  receptors  interacting  with 
antigen and H-2 markers on the stimulator and target cell. 
Data obtained in other studies indicate that a certain degree of cross-reactiv- 
ity  occurs  between  TNP-modified  H-2  haplotypes  as  well  as  between  TNP- 
modified and H-2  allogeneic haplotypes  (13,  14). This would be in  agreement 
with the findings of Lindahl et al. (15) who noted some cross-reactivity between 
haplotypes in H-2 allogeneic CML. The results obtained in this study, as well as 
in those reported by using other haptens for cell modification (6) indicate that T 
cells do not cross kill target cells modified with different but related haptens. 
Therefore, these data are more consistent with the dual or two receptor hypothe- 
sis,  one of which has the  capability of distinguishing  between closely related 
haptens.  A likely possibility for this antigen  receptor is an immunoglobulin V 
region similar to that described in the studies identifying idiotypes on T  cells 
(16,  17).  Consistent  with this postulate,  Klinman  et al.  (18) have shown that 
virgin  B  cells  bear  receptors  with  nonoverlapping  specificities  for  DNP  and 
TNP. 
If T cells have two receptors, one for antigen  (viz. TNP) and the other for self 
H-2 gene products, these may be of low affinity which would explain the lack of 
cross-reactivity between TNP and DNP. Interaction with both receptors would 
be required  for high  avidity binding  between the T  cell and target.  Previous 
results  (15,  16) indicating  cross-reactivity occurs between haplotypes in TNP- 
CML would be consistent with the  receptor for self H-2 products  being  more 
cross reactive, perhaps as a result of relatively few V region genes. This would 
be in agreement with recent estimates indicating that there is a high frequency 
of cytotoxic T cells responding to foreign H-2 haplotypes in CML responses and 
the fact that approximately 10% of clones activated in CML can react with H-2 
unrelated haplotypes (19). 
Summary 
Spleen cells sensitized against trinitrophenyl  (TNP)-modified stimulator cells 
displayed  a  cytotoxic effect against  syngeneic TNP-modified but not  dinitro- 
phenyl  (DNP)-modified  target  cells.  The  same  finding  was  observed  in  the 
opposite direction; that is, effector cells sensitized against DNP-modified stimu- 
lator cells did not cross kill TNP-modified targets.  The specificity of the anti- 
TNP effector cells was confirmed in a  cold target competition assay. 
Presensitization  in  vivo with hapten-modified  cells followed by rechallenge 
and  testing  in  vitro  did not alter  the  specificity of the  response  between the 
haptens.  These  data  indicate  that  the  receptor(s)  on the  cytotoxic T  cell can 
distinguish between two closely related haptenic molecules. 
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